[PDF][PDF] Reproducibility and accuracy of gated SPECT for determination of left ventricular volumes and ejection fraction: experimental validation using MRI
…, WL Bruni, RT Constable, PP Borek… - Journal of Nuclear …, 2000 - Soc Nuclear Med
0.69). The overall LVEFcorrelation between QGS and MRI was poor (r= 0.51). QGS LVEF (mean
±SD, 42% ±3%) overesti mated MRI LVEF (29% ±2%). ConclusIon: QOS provides …
±SD, 42% ±3%) overesti mated MRI LVEF (29% ±2%). ConclusIon: QOS provides …
Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials
AA Bavry, GR Mood, DJ Kumbhani, PP Borek… - American journal of …, 2007 - Springer
Objective This study sought to determine if the initiation of statin (HMG-CoA reductase inhibitor)
therapy during acute coronary syndromes reduces long-term mortality and other adverse …
therapy during acute coronary syndromes reduces long-term mortality and other adverse …
Cardiac venous left ventricular lead removal and reimplantation following device infection: a large single‐center experience
…, G Jackson, B Baranowski, PP Borek… - Journal of …, 2012 - Wiley Online Library
LV Lead Extraction and Reimplantation. Background: Early series of biventricular device
removal have contained mostly younger cardiac venous (CV) left ventricular leads and few …
removal have contained mostly younger cardiac venous (CV) left ventricular leads and few …
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation
…, S Alam, J Sengupta, PP Borek… - Circulation …, 2013 - Am Heart Assoc
Background— Pulmonary vein isolation (PVI) for atrial fibrillation is associated with a
transient increased risk of thromboembolic and hemorrhagic events. We hypothesized that …
transient increased risk of thromboembolic and hemorrhagic events. We hypothesized that …
The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality
KT Ousdigian, PP Borek, JL Koehler… - Circulation …, 2014 - Am Heart Assoc
Background— We classified patients’ atrial fibrillation (AF), assessed its impact on biventricular
pacing (BIVP%), and determined whether AF classification or BIVP% independently …
pacing (BIVP%), and determined whether AF classification or BIVP% independently …
Pacemaker and ICD leads: strategies for long-term management
PP Borek, BL Wilkoff - Journal of interventional cardiac electrophysiology, 2008 - Springer
Pacemaker and defibrillator therapy is on the rise as a result of expanding indications.
Unfortunately, this trend is associated with an increased number of cardiac device-related …
Unfortunately, this trend is associated with an increased number of cardiac device-related …
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory—a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter …
…, KG Tarakji, DO Martin, T Callahan, PP Borek… - Heart Rhythm, 2013 - Elsevier
Background Comparative safety and efficacy associated with transvenous lead extraction (TLE)
of recalled and non-recalled implantable cardioverter-defibrillator (ICD) leads has not …
of recalled and non-recalled implantable cardioverter-defibrillator (ICD) leads has not …
Response to Letter by May et al Regarding Article,“Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation …
…, S Alam, J Sengupta, PP Borek… - Circulation …, 2013 - Am Heart Assoc
Thank you for giving us the opportunity to respond to Dr Fauchier’s valid concerns. Dr
Fauchier et al recommended holding dabigatran for≥ 36 hours preablation and considering …
Fauchier et al recommended holding dabigatran for≥ 36 hours preablation and considering …
[PDF][PDF] Response to Letter by May et al Regarding Article,“Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial …
…, M Khoury, B Abi-Saleh, S Alam, J Sengupta, PP Borek… - researchgate.net
Thank you for giving us the opportunity to respond to Dr Fauchier’s valid concerns. Dr
Fauchier et al recommended holding dabigatran for≥ 36 hours preablation and considering …
Fauchier et al recommended holding dabigatran for≥ 36 hours preablation and considering …
Post-hoc analysis of a randomized, double blind, prospective study at the university of Chicago: Additional standardizations of trial protocol are needed to evaluate the …
…, JS Pyda, A Perez-Gutierrez, P Borek… - Cell …, 2021 - journals.sagepub.com
… There was no statistically significant difference in the secondary endpoints between the
Reparixin and placebo groups in our cohort (P > 0.05). A column presenting data from the …
Reparixin and placebo groups in our cohort (P > 0.05). A column presenting data from the …